Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients
Trial details
- Registry ID
- NCT00280917
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis PatientsNCT00280917 | Can-Fite BioPharma | Phase 2 | Completed | 2007-04Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |